HC Wainwright & Co. analyst Matthew Caufield maintains Surrozen (NASDAQ:SRZN) with a Buy and

HC Wainwright & Co. analyst Matthew Caufield reiterates Surrozen (NASDAQ:SRZN) with a Buy and

Surrozen (NASDAQ:SRZN) reported quarterly losses of $(20.13) per share which missed the analyst cons

Cantor Fitzgerald analyst Steve Seedhouse initiates coverage on Surrozen (NASDAQ:SRZN) with a Ove

Surrozen (NASDAQ:SRZN) reported quarterly losses of $(8.36) per share which missed the analyst conse

On October 14, 2025, Surrozen, Inc. (the "Company") received notice from TCGFB, Inc. ("T

Surrozen (NASDAQ:SRZN) reported quarterly earnings of $2.55 per share which beat the analyst consens

Newly granted patent is part of the expanding intellectual property portfolio directed to:-generatin

HC Wainwright & Co. analyst Matthew Caufield reiterates Surrozen (NASDAQ:SRZN) with a Buy and

Surrozen (NASDAQ:SRZN) reported quarterly losses of $(7.43) per share which missed the analyst conse

HC Wainwright & Co. analyst Matthew Caufield reiterates Surrozen (NASDAQ:SRZN) with a Buy and

Surrozen (NASDAQ:SRZN) reported quarterly losses of $(21.67) per share which missed the analyst cons

HC Wainwright & Co. analyst Matthew Caufield initiates coverage on Surrozen (NASDAQ:SRZN) wit

Guggenheim analyst Yatin Suneja upgrades Surrozen (NASDAQ:SRZN) from Neutral to Buy and maintains

Surrozen (NASDAQ:SRZN) reported quarterly losses of $(0.44) per share which beat the analyst consens

Surrozen (NASDAQ:SRZN) reported quarterly losses of $(0.44) per share which beat the analyst consens

Surrozen, Inc. ("Surrozen" or the "Company") (NASDAQ:SRZN), a company pioneering tar

Surrozen (NASDAQ:SRZN) reported quarterly losses of $(7.99) per share which missed the analyst conse

Targeted protein degradation (TPD*) technologies have demonstrated the potential to produce novel tr

SZN-043 is a novel biotherapeutic shown to potentiate Wnt signaling and induce proliferation of hepa

In preclinical models of cornea endothelial dystrophies, a Surrozen antibody-based Wnt mimetic reduc

Surrozen (NASDAQ:SRZN) reported quarterly losses of $(4.24) per share which beat the analyst consens

Shares of Nuvve Holding Corp. (NASDAQ: NVVE) fell sharply during Monday’s session after the company

Surrozen engages in a private placement, aiming to raise approximately $192.5 million in gross proce

Announces strategic prioritization of clinical programs to focus on development of SZN-043 for Alcoh

Surrozen (NASDAQ:SRZN) reported quarterly losses of $(0.34) per share which missed the analyst conse

Gainers Edible Garden AG Incorporated (NASDAQ: EDBL) shares jumped 58% to $1.88 after the compan

Surrozen (NASDAQ:SRZN) reported quarterly losses of $(0.31) per share. This is a 22.5 percent increa

Surrozen (NASDAQ:SRZN) reported quarterly losses of $(0.48) per share which missed the analyst conse

Companies Reporting Before The Bell • Boyd Gaming (NYSE:BYD) is estimated to report quarterly earni

Gainers

Gainers Hempacco Co., Inc. (NASDAQ: HPCO) rose 296% to $2.99 after declining 6% on Wednesday.

Gainers Elys Game Technology, Corp. (NASDAQ: ELYS) shares jumped 147% to $0.4312. Elys Game Techn

Gainers Neptune Wellness Solutions Inc. (NASDAQ: NEPT) shares rose 106.9% to $0.5482 in pre-marke